Automera
Automera secures $16M in Series A funding co-led by ALSP, ClavystBio
Automera, a new biotechnology company based in Singapore, has secured $16 million in Series A funding co-led by Accelerator Life Science Partners (ALSP) and ClavystBio. The funding also saw participation from Singapore-based global investor EDBI, Xora Innovation, and other undisclosed investors.
